Opyl Limited announces divestment of Opin to focus on AI-driven clinical trial management
Opyl Limited, listed on the Australian Securities Exchange under the ticker ASX:OPL, has entered a significant phase of corporate restructuring with the announcement of a non-binding offer from Trial Screen Pty Ltd, led by Dr. Hugo Stephenson, to acquire its patient candidate recruitment business, Opin. The proposed deal, which includes the divestment of Opin for […]